Australian Pharmaceutical Industries $127 million acquisition of Clearskincare

21/7/2018

Private acquisition

Value:

$ 127 million

Status:

Announced

Date:

21/7/2018

Overview:

Australian Pharmaceutical Industries will initially acquire a 50.1% stake in the clinics business and the whole products business.
API is expected to take over 100% of the clinics business by 2021.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

Australia

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

Australia

Industry sector:

Pharmaceuticals and life sciences

Firms:

Allens

Party: Clearskincare Clinics (Target)

Baker McKenzie

Party: Australian Pharmaceutical Industries Ltd (Acquirer)

Related deals